Can I Take Ashwagandha with Alprostadil (Caverject/MUSE)?

What Is Alprostadil and How Does It Work?

Alprostadil is a synthetic prostaglandin E1 (PGE1) that relaxes smooth muscle in the corpus cavernosum, allowing arterial inflow to produce an erection. It is available as an intracavernosal injection (Caverject, 5-40 mcg) and as a urethral suppository (MUSE, 125-1,000 mcg). The FDA approved Caverject in 1995 and MUSE in 1996 for refractory erectile dysfunction in men who have not responded to or cannot use phosphodiesterase-5 inhibitors.

Mechanism at the Vascular Level

PGE1 binds EP2 and EP3 prostanoid receptors on vascular smooth muscle cells, raising intracellular cyclic AMP (cAMP). Elevated cAMP inhibits myosin light-chain kinase, relaxing arterial walls. The result is localized penile vasodilation, though systemic absorption does occur. A 2002 review in the International Journal of Impotence Research confirmed that systemic alprostadil levels after intracavernosal injection remain low but measurable, accounting for the occasional reports of dizziness and mild hypotension.

Pharmacokinetics: Why CYP Interactions Are Not the Main Worry

Alprostadil undergoes rapid local oxidation to 15-keto-PGE1 and then to 13,14-dihydro-15-keto-PGE1. Roughly 80% of absorbed drug is cleared in a single pass through the pulmonary vasculature. It does not rely on CYP3A4, CYP2D6, or other hepatic cytochrome enzymes for primary clearance. This means that ashwagandha's known modest inhibition of CYP2C9 and CYP3A4 (demonstrated in vitro at supraphysiologic concentrations) is unlikely to raise plasma alprostadil to clinically meaningful levels.

What Is Ashwagandha and Why Do Men With ED Use It?

Ashwagandha (Withania somnifera) is an Ayurvedic adaptogen standardized to withanolide glycosides (typically 5% in KSM-66 and Sensoril extracts). Men with erectile dysfunction often add it hoping to raise testosterone, reduce stress-driven cortisol, and improve sexual function independently of their prescription therapy.

Evidence for Testosterone and Sexual Function

A randomized, double-blind, placebo-controlled trial published in 2019 in Medicine (N=50 men with oligospermia) reported a 14.7% increase in serum testosterone after 90 days of ashwagandha root extract at 675 mg/day. Sexual function scores improved in parallel. A separate 8-week RCT (N=57) published in 2015 in the Journal of the International Society of Sports Nutrition showed a testosterone increase from 630 ng/dL to 726 ng/dL in the ashwagandha group versus no significant change in placebo.

Evidence for Cortisol Reduction

The 2012 trial by Chandrasekhar et al. In the Indian Journal of Psychological Medicine (N=64) found that 300 mg twice daily of a high-concentration full-spectrum ashwagandha root extract reduced serum cortisol by 27.9% compared to placebo (P<0.001) at 60 days. Chronic elevated cortisol is independently associated with suppressed gonadotropin-releasing hormone pulsatility, so this cortisol reduction may partly explain the testosterone rises seen in stressed populations.

The Core Interaction Concern: Additive Hypotension

The single most clinically relevant concern when combining ashwagandha with alprostadil is a pharmacodynamic one: both agents reduce blood pressure through distinct but additive pathways. Low blood pressure after alprostadil injection is already a listed adverse event, and ashwagandha independently reduces systolic blood pressure.

Alprostadil's Hypotensive Profile

Prescribing information for Caverject (alprostadil for injection) states that hypotension occurs in approximately 2% of patients. In clinical trials reviewed for the FDA approval package, dizziness (a surrogate for symptomatic hypotension) was reported in 1-3% of men using the intracavernosal formulation. The MUSE suppository delivers higher systemic doses, making hypotension more common at therapeutic levels.

Ashwagandha's Hypotensive Effect

A meta-analysis published in 2021 in Phytomedicine pooled five RCTs (N=491 participants) and found that ashwagandha supplementation reduced systolic blood pressure by a mean of 5.05 mmHg (95% CI 1.81-8.29) and diastolic by 2.85 mmHg (95% CI 1.02-4.68) compared to placebo. A 5-10 mmHg systolic reduction is modest in isolation, but stacked on top of alprostadil-mediated vasodilation immediately after injection, it could produce symptomatic lightheadedness, especially in men who are already on antihypertensive therapy.

Who Is at Highest Risk

Men taking three or more antihypertensive agents, those with baseline systolic blood pressure below 100 mmHg, and men using the MUSE 1,000 mcg suppository (the highest available dose) carry the most risk from additive hypotension. Men using low-dose Caverject (5-10 mcg) for mild to moderate ED are at lower absolute risk but should still be aware of the interaction.

Ashwagandha's Thyroid Effect: Relevance to Erectile Function

Ashwagandha raises circulating thyroid hormones in men with subclinical hypothyroidism. A randomized trial published in the Journal of Alternative and Complementary Medicine (N=50, 8 weeks at 600 mg/day) demonstrated significant increases in serum T3 and T4 with normalized TSH. Subclinical hypothyroidism is a recognized contributor to erectile dysfunction, so this is generally a favorable effect. However, men already on levothyroxine should have their thyroid function rechecked 6-8 weeks after starting ashwagandha, because unexpected T3/T4 rises could cause tachycardia, which would compound the cardiovascular stress of alprostadil-related hemodynamic shifts.

Pharmacokinetic Deep Dive: CYP Enzymes and Herb-Drug Interactions

The table below summarizes what is and is not a concern at the enzyme level.

| Pathway | Alprostadil reliance | Ashwagandha effect | Clinical risk | |---|---|---|---| | CYP3A4 | Negligible | Mild in vitro inhibition | Low | | CYP2C9 | Negligible | Mild in vitro inhibition | Low | | CYP2D6 | None documented | Not reported | Negligible | | Pulmonary oxidation (15-PGDH) | Primary route | No interaction documented | None | | P-glycoprotein | Not a substrate | Withanolides may modulate | Theoretical only |

Because alprostadil is cleared almost entirely by local and pulmonary enzymatic oxidation rather than hepatic CYP metabolism, the herb-drug pharmacokinetic interaction is not a primary clinical concern. The pharmacodynamic overlap (blood pressure, cardiovascular tone) is where attention belongs.

Cortisol, the HPA Axis, and ED: A Hormonal Picture

Cortisol suppression by ashwagandha may indirectly benefit men with psychogenic or mixed-etiology ED. Elevated cortisol blunts luteinizing hormone (LH) pulsatility from the pituitary, which reduces Leydig cell testosterone production. Men with documented high cortisol and low-normal testosterone may see a modest testosterone rise from ashwagandha before they ever adjust their alprostadil dose. This is generally helpful, but it means that over time, some patients using both agents may require lower alprostadil doses to achieve adequate erections, because improved endogenous erectile function reduces the needed pharmacological stimulus.

The Endocrine Society's 2018 guideline on male hypogonadism, published in the Journal of Clinical Endocrinology and Metabolism, notes that stress-related hypercortisolemia is an underrecognized secondary cause of low testosterone. Ashwagandha does not replace testosterone therapy, but its cortisol-lowering effects are a physiologically plausible path to modest testosterone improvement in stressed men.

Monitoring Protocol When Using Both

Before You Start

Check a baseline blood pressure reading at rest. If your systolic is below 110 mmHg consistently, discuss the addition of ashwagandha with your prescriber before starting. Also obtain baseline serum testosterone, TSH, free T3, and free T4 if you have any history of thyroid disease.

During Concurrent Use

Sit or lie down for at least 30 minutes after each alprostadil administration. This is standard alprostadil safety advice regardless of other supplements, but it becomes more important when a background vasodilatory supplement is on board. If you experience persistent dizziness, palpitations, or syncope, stop ashwagandha and contact your provider.

Dose Timing

No formal dose-separation window has been studied for this combination. The pharmacodynamic rationale, however, supports taking ashwagandha with your morning or evening meal and using alprostadil no sooner than two hours after the last ashwagandha dose on days when both are used. Ashwagandha's peak cortisol suppression and modest blood pressure effect occur within 1-2 hours of ingestion; separating the timing by at least two hours gives the ashwagandha effect partial time to attenuate before you add localized PGE1 vasodilation.

Ashwagandha Dose to Choose

Clinical trials showing meaningful testosterone and cortisol effects used 300-600 mg of a standardized root extract (5% withanolides) twice daily. Doses above 1,000 mg/day have not demonstrated proportionally greater benefit and may amplify GI side effects. Staying within the 300-600 mg range reduces any theoretical additive BP risk compared to higher, unstudied doses.

What If You Are Already Taking Both?

If you are currently taking ashwagandha and alprostadil without problems, that is useful information. Absence of symptoms after several uses suggests you are not among the minority experiencing additive hypotension. Tell your prescribing physician about the ashwagandha at your next visit. The American Urological Association 2018 ED Guideline states that a complete medication and supplement history is a core component of ED management, yet surveys consistently find fewer than 30% of men disclose supplement use to their urologist.

The conversation matters for two reasons. First, your provider may want to titrate your alprostadil dose downward if ashwagandha has genuinely improved your baseline erectile function. Second, if you develop unexpected dizziness after an injection, your provider needs to know about the supplement to make an accurate diagnosis.

Ashwagandha Compared to Other ED Supplements Taken With Alprostadil

Ashwagandha is not the highest-risk supplement to combine with alprostadil. That distinction belongs to agents with direct nitric oxide-enhancing activity, such as L-arginine at doses above 3 grams and yohimbine (which raises blood pressure in some men but can also cause paradoxical hypotension). Ashwagandha's blood pressure effects are milder than L-arginine at standard doses and are generally a hypotensive direction rather than mixed.

Ginkgo biloba and Panax ginseng also appear in ED supplement stacks. Ginkgo carries a platelet-inhibiting effect that could theoretically increase bruising at injection sites. Ginseng shares some adrenal-modulating properties with ashwagandha but has its own separate evidence base. If you are using a combination ED supplement that includes ashwagandha, L-arginine, and ginseng together with alprostadil, the interaction complexity rises and a formal pharmacist or physician review of the full stack is warranted.

Clinical Evidence Summary for Ashwagandha in Sexual Function

Three placebo-controlled trials with direct sexual function endpoints are worth noting:

1. A 2015 pilot RCT (N=57) in the Journal of the International Society of Sports Nutrition showed significant improvements in self-reported sexual health scores alongside the testosterone increase described above.

2. The 2019 trial in Medicine (N=50) showed improved semen parameters and sexual function scores after 90 days of ashwagandha.

3. A 2022 RCT specifically designed to test ashwagandha's effect on sexual function in healthy adult men and women (N=80, 8 weeks, 600 mg/day) published in Health Science Reports found statistically significant improvements in total FSFI/IIEF score, orgasm, and satisfaction domains compared to placebo. No serious adverse events were reported.

None of these trials included men on concurrent alprostadil. The absence of trial data does not mean danger; it means the combination has not been formally tested, so clinical judgment and monitoring take the place of trial-level certainty.

Special Populations

Men With Cardiovascular Disease

Alprostadil is one of the preferred ED treatments for men with cardiovascular disease because, unlike PDE5 inhibitors, it carries no contraindication with nitrate medications. However, men with heart failure or poorly controlled hypertension already on multiple vasodilators should approach ashwagandha with caution. The additive blood pressure lowering effect could require antihypertensive dose adjustments.

Men With Autoimmune Conditions

Ashwagandha has immunostimulatory properties at standard doses. Men on immunosuppressive therapy should consult their specialist before adding ashwagandha, though this concern does not directly alter the alprostadil interaction.

Men Over 65

Older men have reduced baroreceptor sensitivity, making them more vulnerable to symptomatic hypotension from any vasodilatory agent. The sit-or-lie-down protocol after alprostadil injection is especially important in this age group.